Autopsy report · NCT03993613

Apotransferrin in Patients With β-thalassemia

“no availability of IMP for this study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months after it had already started.
• Ran for about 3 years before it stopped.
• 10 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Prothya Biosolutions

Sponsor type

Industry

Conditions

β-thalassemia Intermedia

Interventions

human apotransferrin

Participants

10

Sites

1

Countries

Netherlands

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.